Brian Landry

Title: Brian Landry: Innovator in Non-Invasive Prenatal Testing

Introduction

Brian Landry is a notable inventor based in Palo Alto, CA, who has made significant contributions to the field of prenatal testing. With a focus on developing innovative methodologies, he has been awarded 2 patents that enhance the accuracy and efficiency of prenatal diagnostics.

Latest Patents

One of Brian's latest patents is a highly accurate non-invasive prenatal testing methodology that allows for accurate fetal rhesus determination and fetal DNA fraction measurement in a single assay. This testing can be administered as early as week 10 of pregnancy and can be conveniently combined with prenatal genetic disease testing and detection. Another significant patent involves a method and/or system for generating a co-amplified mixture based on co-amplifying a set of nucleic acid molecules from a biological sample. This method facilitates the characterization of medical conditions by determining abundance metrics for genomic regions of interest.

Career Highlights

Brian Landry is currently employed at Billiontoone, Inc., where he continues to push the boundaries of prenatal testing technology. His work is instrumental in providing expectant parents with critical information about their pregnancies at earlier stages than previously possible.

Collaborations

Throughout his career, Brian has collaborated with talented individuals such as David Tsao and Oguzhan Atay, contributing to a dynamic and innovative work environment.

Conclusion

Brian Landry's contributions to non-invasive prenatal testing represent a significant advancement in medical technology. His innovative patents and ongoing work at Billiontoone, Inc. continue to pave the way for improved prenatal diagnostics.